The Immunogenicity and Safety of 2013-2014 Seasonal Trivalent Influenza Vaccine
NCT02269852
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
182
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
trivalent seasonal influenza vaccine
Sponsor
Sinovac Biotech Co., Ltd